ea0056p972 | Male Reproduction | ECE2018
Alzoubi Abdallah
, Alsmairat Aya
, Al Bashir Samir
, Alfaqih Mahmoud
, Kheirallah Khalid
Background: Prostate cancer is the second leading cause of cancer-related deaths in men worldwide. A marker of poor survival in prostate cancer patients is the loss of the tumor suppressor gene PTEN (phosphoinositide-3-phosphatase). Deletion of PTEN occurs in approximately 40% of prostate cancer patients, and is associated with early biochemical recurrence, metastatic potential, and androgen-independence. Androgen-deprivation-therapy (ADT) remains the princip...